Theme: Shaping the Future of Cancer Research and Oncology Through Scientific Excellence


The 2nd International Conference on Cancer Research & Oncology, taking place from October 18–20, 2027, in Milan, Italy, is a distinguished global forum dedicated to advancing scientific knowledge and fostering collaboration in the field of cancer research and oncology. Centered on the theme, "Shaping the Future of Cancer Research and Oncology Through Scientific Excellence," the conference will bring together leading oncologists, cancer researchers, clinicians, academicians, healthcare professionals, pharmaceutical and biotechnology experts, and industry leaders from around the world. It will provide an exceptional platform for presenting groundbreaking research, sharing clinical experiences, and exploring innovative strategies that are transforming cancer prevention, diagnosis, treatment, and patient care.
The conference will showcase the latest developments in precision oncology, immunotherapy, molecular diagnostics, targeted therapies, cancer genomics, translational research, artificial intelligence in oncology, clinical trials, radiation oncology, surgical oncology, and personalized medicine. Through inspiring keynote lectures, scientific sessions, panel discussions, workshops, poster presentations, and networking opportunities, participants will gain valuable insights into emerging technologies, evidence-based clinical practices, and multidisciplinary approaches that are shaping the future of oncology. The conference aims to strengthen global collaborations, encourage scientific excellence, and accelerate the translation of research discoveries into meaningful clinical solutions that improve patient outcomes while driving the next generation of cancer research and oncology.

Cancer Biology Molecular Oncology focuses on understanding the fundamental biological and molecular mechanisms that drive cancer initiation, progression, metastasis, and therapeutic resistance. This field explores the genetic, epigenetic, and cellular alterations that transform normal cells into malignant tumors, providing critical insights into tumor development and disease progression. Advances in molecular oncology have significantly improved the identification of cancer biomarkers,…
Precision Oncology Personalized Medicine focuses on delivering individualized cancer care by tailoring prevention, diagnosis, and treatment strategies based on each patient's genetic, molecular, and clinical profile. Advances in genomics, biomarker discovery, molecular diagnostics, and targeted therapies have transformed oncology, enabling more accurate treatment selection, improved therapeutic responses, and reduced treatment-related toxicity. This personalized approach is paving the way for…
Cancer Genomics Epigenetics explores the genetic and epigenetic changes that contribute to cancer development, progression, and therapeutic response. Advances in next-generation sequencing, genomic profiling, and epigenetic research have enhanced our understanding of tumor biology, enabling the identification of disease-associated mutations, biomarkers, and therapeutic targets. These discoveries are driving the development of precision medicine and improving the diagnosis, prognosis, and…
Immuno-Oncology Immunotherapy focuses on harnessing the body's immune system to prevent, control, and treat cancer through innovative therapeutic approaches. Significant advances in immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, adoptive cell therapies, and combination immunotherapies have transformed cancer treatment, offering improved survival and long-term clinical benefits for many patients. This rapidly evolving field continues to expand the possibilities…
Clinical Oncology Cancer Care focuses on the comprehensive management of cancer patients through evidence-based diagnosis, treatment, and supportive care. This field integrates medical, surgical, and radiation oncology with multidisciplinary approaches to deliver personalized treatment plans that improve survival, enhance quality of life, and optimize patient outcomes. Continuous advancements in clinical research, targeted therapies, immunotherapy, and precision medicine are transforming…







































































“We’re Here To Redefine The Conference, Making It Not Just Informative But Truly Inspiring And Memorable Conference.”